VUZELOR Trademark

Trademark Overview


On Monday, September 28, 2020, a trademark application was filed for VUZELOR with the United States Patent and Trademark Office. The USPTO has given the VUZELOR trademark a serial number of 90217123. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 19, 2022. This trademark is owned by Eli Lilly and Company. The VUZELOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
vuzelor

General Information


Serial Number90217123
Word MarkVUZELOR
Filing DateMonday, September 28, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 19, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 23, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
Pseudo MarkVU ZEL OR

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 10, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, December 19, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 19, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, April 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 20, 2022SOU EXTENSION 2 GRANTED
Wednesday, April 20, 2022SOU EXTENSION 2 FILED
Wednesday, April 20, 2022TEAS EXTENSION RECEIVED
Wednesday, November 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 2, 2021SOU EXTENSION 1 GRANTED
Monday, October 25, 2021SOU EXTENSION 1 FILED
Tuesday, November 2, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 25, 2021TEAS EXTENSION RECEIVED
Tuesday, May 18, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 23, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 18, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 18, 2021ASSIGNED TO EXAMINER
Tuesday, November 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 1, 2020NEW APPLICATION ENTERED IN TRAM